These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 19659999)
1. Effects of UCP2 -866 G/A and ADRB3 Trp64Arg on rosiglitazone response in Chinese patients with Type 2 diabetes. Yang M; Huang Q; Wu J; Yin JY; Sun H; Liu HL; Zhou HH; Liu ZQ Br J Clin Pharmacol; 2009 Jul; 68(1):14-22. PubMed ID: 19659999 [TBL] [Abstract][Full Text] [Related]
2. Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes. Liu HL; Lin YG; Wu J; Sun H; Gong ZC; Hu PC; Yin JY; Zhang W; Wang D; Zhou HH; Liu ZQ Eur J Clin Pharmacol; 2008 Jul; 64(7):663-71. PubMed ID: 18438653 [TBL] [Abstract][Full Text] [Related]
3. Impact of retinol binding protein 4 polymorphism on rosiglitazone response in Chinese type 2 diabetic patients. Zhou F; Huang Q; Dai X; Yin J; Wu J; Zhou H; Gong Z; Liu Z Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):949-57. PubMed ID: 22086013 [TBL] [Abstract][Full Text] [Related]
4. The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. Sun H; Gong ZC; Yin JY; Liu HL; Liu YZ; Guo ZW; Zhou HH; Wu J; Liu ZQ Br J Clin Pharmacol; 2008 Jun; 65(6):917-26. PubMed ID: 18429970 [TBL] [Abstract][Full Text] [Related]
5. The presence of at least three alleles of the ADRB3 Trp64Arg (C/T) and UCP1 -3826A/G polymorphisms is associated with protection to overweight/obesity and with higher high-density lipoprotein cholesterol levels in Caucasian-Brazilian patients with type 2 diabetes. Brondani LA; Duarte GC; Canani LH; Crispim D Metab Syndr Relat Disord; 2014 Feb; 12(1):16-24. PubMed ID: 24138564 [TBL] [Abstract][Full Text] [Related]
6. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes. Wang S; Se YM; Liu ZQ; Lei MX; Hao-BoYang ; Sun ZX; Nie SD; Zeng XM; Wu J Pharmazie; 2012 Jan; 67(1):74-9. PubMed ID: 22393835 [TBL] [Abstract][Full Text] [Related]
7. NeuroD1 A45T and PAX4 R121W polymorphisms are associated with plasma glucose level of repaglinide monotherapy in Chinese patients with type 2 diabetes. Gong ZC; Huang Q; Dai XP; Lei GH; Lu HB; Yin JY; Xu XJ; Qu J; Pei Q; Dong M; Zhou BT; Shen J; Zhou G; Zhou HH; Liu ZQ Br J Clin Pharmacol; 2012 Sep; 74(3):501-9. PubMed ID: 22296034 [TBL] [Abstract][Full Text] [Related]
8. Effects of NOS1AP rs12742393 polymorphism on repaglinide response in Chinese patients with type 2 diabetes mellitus. Wang T; Wang Y; Lv DM; Song JF; Lu Q; Gao X; Zhang F; Guo H; Li W; Yin XX Pharmacotherapy; 2014 Feb; 34(2):131-9. PubMed ID: 24338736 [TBL] [Abstract][Full Text] [Related]
9. Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus. Zhang KH; Huang Q; Dai XP; Yin JY; Zhang W; Zhou G; Zhou HH; Liu ZQ J Clin Pharmacol; 2010 Sep; 50(9):1022-30. PubMed ID: 20498286 [TBL] [Abstract][Full Text] [Related]
10. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Huang Q; Yin JY; Dai XP; Pei Q; Dong M; Zhou ZG; Huang X; Yu M; Zhou HH; Liu ZQ Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342 [TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Miyazaki Y; DeFronzo RA Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983 [TBL] [Abstract][Full Text] [Related]
12. Serine racemase rs391300 G/A polymorphism influences the therapeutic efficacy of metformin in Chinese patients with diabetes mellitus type 2. Dong M; Gong ZC; Dai XP; Lei GH; Lu HB; Fan L; Qu J; Zhou HH; Liu ZQ Clin Exp Pharmacol Physiol; 2011 Dec; 38(12):824-9. PubMed ID: 21933224 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study. Chappuis B; Braun M; Stettler C; Allemann S; Diem P; Lumb PJ; Wierzbicki AS; James R; Christ ER Diabetes Metab Res Rev; 2007 Jul; 23(5):392-9. PubMed ID: 17211855 [TBL] [Abstract][Full Text] [Related]
14. Impact of GNB3-C825T, ADRB3-Trp64Arg, UCP2-3'UTR 45 bp del/ins, and PPARγ-Pro12Ala polymorphisms on Bofutsushosan response in obese subjects: a randomized, double-blind, placebo-controlled trial. Park J; Bose S; Hong SW; Lee DK; Yoo JW; Lim CY; Lee M; Kim H J Med Food; 2014 May; 17(5):558-70. PubMed ID: 24827746 [TBL] [Abstract][Full Text] [Related]
15. [The effect of single nucleotide polymorphism SNP + 45 of the adiponectin gene on the rosiglitazone maleate response in patients with type 2 diabetes]. Zhang H; Jia WP; Hu C; Zhang R; Wang CR; Bao YQ; Lu JX; Xu J; Xiang KS Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2390-3. PubMed ID: 18036314 [TBL] [Abstract][Full Text] [Related]
16. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Huang Q; Yin JY; Dai XP; Wu J; Chen X; Deng CS; Yu M; Gong ZC; Zhou HH; Liu ZQ Eur J Clin Pharmacol; 2010 Dec; 66(12):1207-15. PubMed ID: 20809084 [TBL] [Abstract][Full Text] [Related]
17. [The Trp64Arg polymorphism of beta3-adrenoreceptor gene study in persons with overweight and obesity]. Baturin AK; Pogozheva AV; Sorokina EIu; Makurina ON; Tutel'ian VA Vopr Pitan; 2012; 81(2):23-7. PubMed ID: 22774474 [TBL] [Abstract][Full Text] [Related]
18. [Study on relationship between Trp64Arg polymorphism of β3-adrenergic receptor gene and obesity and blood lipids]. Liu J; Zhang B; Li M; Li C; Liu Y; Wang Z; Wen J; Wen S Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1558-62. PubMed ID: 26463601 [TBL] [Abstract][Full Text] [Related]
19. NAMPT -3186C/T polymorphism affects repaglinide response in Chinese patients with Type 2 diabetes mellitus. Sheng FF; Dai XP; Qu J; Lei GH; Lu HB; Wu J; Xu XJ; Pei Q; Dong M; Liu YZ; Zhou HH; Liu ZQ Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):550-4. PubMed ID: 21631570 [TBL] [Abstract][Full Text] [Related]
20. Effect of the combination of the variants -75G/A APOA1 and Trp64Arg ADRB3 on the risk of type 2 diabetes (DM2). Morcillo S; Cardona F; Rojo-Martínez G; Almaraz MC; Esteva I; Ruiz-De-Adana MS; Olveira G; García-Fuentes E; Gómez-Zumaquero JM; Soriguer F Clin Endocrinol (Oxf); 2008 Jan; 68(1):102-7. PubMed ID: 17727676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]